Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Analysts target

<< Previous

Bullboard Posts

Next >>

Comment by Sciotoon Jul 25, 2020 9:17am

158 Views

Post# 31318424

RE:RE:RE:RE:Analysts target

good insight. The after hours trading the other night was nuts. The market is frothy and a lot of momentum manipulation on news. You may remember in the spring I encouraged us to push news out on the company to sites like stock twits. Now granted that's not the same level of evaluation and stock understanding as stock house but it is a popular site in America. Following has grown. There were 53 followers and early May and now there's over 550. When you look at these big price spikes, and we've had a few, it does attract spikes in followers.

<< Previous

Bullboard Posts

Next >>

Yukon agency detects cyanide near Victoria Gold's Eagle mine